“…Glycosylation of nucleobases with 2-fluorinated glycosyl donors bearing various common anomeric leaving groups (e.g., −Cl, −Br, −OAc, −OBz) offered access to sofosbuvir, clofarabine, gemcitabine, and other 2′-fluoro-2′-deoxypyrimidine and 2′-fluoro-2′-deoxypurine nucleosides. , The glycosylation normally requires higher temperatures and prolonged reaction times to give mixtures of regio- and/or stereo-isomeric products. This likely results from the slow formation of reactive oxocarbenium species , by the inductive effect of the 2′-fluoro substituent. Derivatization of simple or available 2′-fluoro-2′-deoxynucleosides represents another general approach to increase the complexity of the fluorosugar moiety that can limit off-target effects and improve safety profiles.…”